Dose-Response Effect and Dose-Toxicity in Stereotactic Radiotherapy for Brain Metastases: A Review

Dose-Response Effect and Dose-Toxicity in Stereotactic Radiotherapy for Brain Metastases: A Review

For more than two decades, stereotactic radiosurgery has been considered a cornerstone treatment for patients with limited brain metastases. Historically, radiosurgery in a single fraction has been the standard of care but recent technical advances have also enabled the delivery of hypofractionated...

Full description

Bibliographic Details
Main Authors:	Maxime Loo, Jean-Baptiste Clavier, Justine Attal Khalifa, Elisabeth Moyal, Jonathan Khalifa
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Cancers
Subjects:	stereotactic radiotherapy radiosurgery brain metastases fractionation dose-effect relation
Online Access:	https://www.mdpi.com/2072-6694/13/23/6086

Similar Items

Stereotactic Radiosurgery and Stereotactic Fractionated Radiotherapy in the Management of Brain Metastases
by: Sofian Benkhaled, et al.
Published: (2024-03-01)

Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases
by: Leonie Johannwerner, et al.
Published: (2023-04-01)

Stereotactic radiosurgery of brain metastases: a retrospective study
by: Isabella Gruber, et al.
Published: (2023-12-01)

Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review
by: Yining Gong, et al.
Published: (2019-10-01)

Neoadjuvant Stereotactic Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis of the Literature and Ongoing Clinical Trials
by: Paolo Palmisciano, et al.
Published: (2022-09-01)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
by: Tyler Gutschenritter, et al.
Published: (2020-12-01)

Overall survival following stereotactic radiosurgery for ten or more brain metastases: a systematic review and meta-analysis
by: Hamoun Rozati, et al.
Published: (2023-10-01)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
by: Rosario Mazzola, et al.
Published: (2019-04-01)

Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases—Implications for Intraoperative Radiotherapy after Resection
by: Carsten Herskind, et al.
Published: (2017-07-01)

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
by: Giuseppe Minniti, et al.
Published: (2019-04-01)

Dose-effect relationship of linear accelerator based stereotactic radiotherapy for brain metastases
by: Ning Wu, et al.
Published: (2023-10-01)

Efficiency of Stereotactic Conformal Radiotherapy in Lung Metastases with Active Breathing Control
by: Olga Yu. Anikeeva, PhD, et al.
Published: (2013-06-01)

Repeated Stereotactic Radiotherapy for Local Brain Metastases Failure or Distant Brain Recurrent: A Retrospective Study of 184 Patients
by: Laure Kuntz, et al.
Published: (2023-10-01)

Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients
by: L. Kuntz, et al.
Published: (2023-01-01)

Single fraction stereotactic radiosurgery and fractionated stereotactic radiotherapy provide equal prognosis with overall survival in patients with brain metastases at diagnosis without surgery at primary site
by: Garett Paul Ostdiek-Wille, et al.
Published: (2023-05-01)

Stereotactic radiosurgery for the treatment of brainstem metastases: a multicenter retrospective study
by: Luca Nicosia, et al.
Published: (2022-08-01)

Deep-learning-driven dose prediction and verification for stereotactic radiosurgical treatment of isolated brain metastases
by: Jinghui Pan, et al.
Published: (2023-11-01)

Acute toxicities and cumulative dose to the brain of repeated sessions of stereotactic radiotherapy (SRT) for brain metastases: a retrospective study of 184 patients
by: L. Kuntz, et al.
Published: (2023-01-01)

Volumetric reduction of brain metastases after stereotactic radiotherapy: Prognostic factors and effect on local control
by: Naoyuki Kanayama, et al.
Published: (2022-12-01)

Stereotactic Radiosurgery/Radiotherapy: A Historical Review
by: Mansoureh Nabavi, et al.
Published: (2014-04-01)

Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases
by: Masanori Hirata, et al.
Published: (2022-12-01)

Evaluation of Biological Effective Dose in Gamma Knife Staged Stereotactic Radiosurgery for Large Brain Metastases
by: Taoran Cui, et al.
Published: (2022-06-01)

SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases
by: J. A. Crouzen, et al.
Published: (2023-03-01)

Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial
by: Jaap D. Zindler, et al.
Published: (2017-07-01)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
by: Julia Malone, BSC, et al.
Published: (2020-11-01)

Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level
by: A. van Linge, et al.
Published: (2018-12-01)

Dose Reduction to Motor Structures in Adjuvant Fractionated Stereotactic Radiotherapy of Brain Metastases: nTMS-Derived DTI-Based Motor Fiber Tracking in Treatment Planning
by: Christian D. Diehl, et al.
Published: (2022-12-01)

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
by: Barney Brandon M, et al.
Published: (2012-05-01)

Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy
by: Megumi Uto, et al.
Published: (2021-07-01)

A feasibility study of stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy practice using tomoedge in helical tomotherapy for lung, liver, and spine targets
by: N V. N. Madhusudhana Sresty, et al.
Published: (2021-01-01)

Ipilimumab and Stereotactic Radiosurgery with CyberKnife<sup>®</sup> System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience
by: Valentina Borzillo, et al.
Published: (2021-04-01)

An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases
by: Shouliang Ding, et al.
Published: (2023-05-01)

Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)
by: Paul Lesueur, et al.
Published: (2018-07-01)

Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial
by: Maria Waltenberger, et al.
Published: (2023-07-01)

Single-fraction SRS and multiple-fraction SRT for brain metastases from colorectal cancer
by: Yong Li, et al.
Published: (2022-12-01)

Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
by: Benoît Calderon, et al.
Published: (2023-07-01)

Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases
by: Raees Tonse, et al.
Published: (2021-07-01)

Preoperative stereotactic radiosurgery in the management of brain metastases and gliomas
by: Eric J. Lehrer, et al.
Published: (2022-10-01)

Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
by: Conti Alfredo, et al.
Published: (2019-11-01)

Toxicity Profiles of Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenomas
by: Chia-Lun Chang, et al.
Published: (2019-10-01)